Phosphoinositide 3-kinase (PI3K) activity is stimulated by diverse oncogenes and growth factor receptors, and elevated PI3K signaling is considered a hallmark of cancer and is a key therapeutic target in the treatment of cancer35. The gene discussed is PIK3CD; the disease is cancer.